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Background: Genome-wide association studies have identified variants associated with obesity-related traits, such
as the body mass index (BMI). We sought to determine how the combination of 31 validated, BMI-associated loci
contributes to obesity- and diabetes-related traits in a French population sample. The MONA LISA Lille study (1578
participants, aged 35–74) constitutes a representative sample of the population living in Lille (northern France).
Genetic variants were considered both individually and combined into a genetic predisposition score (GPS).
Results: Individually, 25 of 31 SNPs showed directionally consistent effects on BMI. Four loci (FTO, FANCL, MTIF3 and
NUDT3) reached nominal significance (p ≤ 0.05) for their association with anthropometric traits. When considering
the combined effect of the 31 SNPs, each additional risk allele of the GPS was significantly associated with an
increment in the mean [95% CI] BMI of 0.13 [0.07-0.20] kg/m2 (p = 6.3x10−5) and a 3% increase in the risk of obesity
(p = 0.047). The GPS explained 1% of the variance in the BMI. Furthermore, the GPS was associated with higher
fasting glycaemia (p = 0.04), insulinaemia (p = 0.008), HbA1c levels (p = 0.01) and HOMA-IR scores (p = 0.0003) and a
greater risk of type 2 diabetes (OR [95% CI] = 1.06 [1.00-1.11], p = 0.03). However, these associations were no longer
statistically significant after adjustment for BMI.
Conclusion: Our results show that the GPS was associated with a higher BMI and an insulin-resistant state
(mediated by BMI) in a population in northern France.
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According to the World Health Organization (WHO)’s
criterion for obesity (body mass index (BMI) ≥ 30 kg/m2),
up to 15% of the adults in Europe are obese [1]. The
prevalence of obesity has more or less doubled since 1980
[2]. Obesity is a serious public health issue worldwide. In-
deed, there is a well-documented relationship between a
high BMI on one hand and mortality and morbidity due
to chronic diseases (such as cardiovascular disease, certain
cancers, type 2 diabetes (T2D) and osteoarthritis) on the
other [3]. Accordingly, the WHO has declared obesity to
be a global epidemic that affects both industrialized and
non-industrialized countries [4].* Correspondence: Aline.Meirhaeghe@pasteur-lille.fr
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unless otherwise stated.Body fat mass is influenced by the combination of gen-
etic factors and lifestyle factors (such as diet and physical
activity). Family and twin studies have shown that genetic
factors account for 40–70% of the population variation in
BMI [5,6]; this may explain why people are not all equally
affected by obesity in an obesogenic environment [7].
Genome-wide association studies (GWASs) have sought
to elucidate the genetic basis of obesity and its related traits.
To date, 32 genetic loci have been unequivocally associated
with BMI [8]. Several studies have replicated these associa-
tions and have taken account of the combined impact of
these GWAS-validated loci when considering BMI and
other obesity-related phenotypes [8,9]. The objective of the
present study was to replicate the combined effects of the
established BMI-associated loci on BMI, body fat percen-
tage, waist circumference, waist-to-hip ratio (WHR) and
obesity risk in a representative sample of the general popu-
lation in northern France (n = 1578). Furthermore, the highal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 Effect of the genetic predisposition score on
anthropometric variables in the MONA LISA Lille study
(n = 1546)
Parameter β SE LCL UCL p1 p2
BMI (kg/m2) 0.13 0.03 0.07 0.20 6.3x10−5 -
Body fat (%) 0.14 0.05 0.05 0.24 0.004 -
Waist (cm) 0.28 0.09 0.11 0.45 0.001 0.65
Hip (cm) 0.24 0.07 0.11 0.37 3.7x10−4 0.74
Waist-to-hip ratio 0.0006 0.0004 −0.0003 0.0015 0.19 0.41
The β coefficients represent the effect sizes. SE: standard error. LCL: lower
confidence limit; UCL: upper confidence limit.
1p values were adjusted for age, gender, physical activity, smoking status and
alcohol consumption. 2p values were adjusted for age, gender, physical
activity, smoking status, alcohol consumption and BMI.
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insulin resistance and T2D) prompted us to test the impact
of the BMI-associated loci on glucose-related traits and the
risk of T2D.
Results
Characteristics of the MONA LISA Lille study
The characteristics of the study participants are summa-
rized in Additional file 1: Table S1. Of the 1578 indivi-
duals, 37.3% were overweight, 22.4% were obese, and 9.2%
had T2D. We selected 32 single nucleotide polymor-
phisms (SNPs) in or near the genes listed hereafter and
that are known to be associated with BMI: FTO, MC4R,
TMEM18, GNPDA2, BDNF, NEGR1, SH2B1, ETV5,
MTCH2, KCTD15, TFAP2B, NRXN3, FAIM2, SEC16B,
RBJ-ADCY3-POMC, GPRC5B, MAP2K5-LBXCOR1, QP
CTL-GIPR, TNNI3K, SLC39A8, FLJ35779-HMGCR, LR
RN6C, TMEM160, FANCL, CADM2, PRKD1, LRP1B,
PTBP2, MTIF3-GTF3A, RPL27A-TUB, NUDT3-HMGA1
and ZNF608 [8]. Genotyping of the ZNF608 rs4836133
SNP failed and so the remaining 31 SNPs were investi-
gated further.
Single-variant analyses
All SNPs conformed to Hardy-Weinberg equilibrium
(Additional file 1: Table S2). As the sample size was rela-
tively small and the statistical power limited, no SNPs
were significantly associated with any of the anthropomet-
ric parameters. Only the FTO rs9939609 and FANCL
rs887912 SNPs were nominally associated with BMI (β ±
SE = 0.49 ± 0.19 kg/m2, p = 0.008 and β ± SE = 0.54 ±
0.19 kg/m2, p = 0.005, respectively). Of the 31 tested SNPs,
25 were directionally consistent with the results reported
in the original GWAS on BMI (Additional file 1: Table
S3). This number was higher than that expected by chance
(p = 0.0003 in a binomial test). Some SNPs were nominally
associated with continuous anthropometric traits other
than BMI (such as body fat percentage and hip and waist
circumferences). The FTO rs9939609 and FANCL rs887912
SNPs were nominally associated with body fat percentage
(β ± SE = 0.53 ± 0.27%, p = 0.05 and β ± SE = 0.69 ± 0.28%,
p = 0.01, respectively). We also observed nominal associa-
tions between the FANCL rs887912 SNP and waist and hip
circumferences (β ± SE = 1.03 ± 0.50 cm, p = 0.04 and β ±
SE = 0.89 ± 0.39 cm, p = 0.02, respectively), between
the MTIF3 rs4771122 SNP and hip circumference
(β ± SE = 0.84 ± 0.42 cm, p = 0.04) and between the
NUDT3 rs206936 SNP and WHR (β ± SE = −0.007 ±
0.003, p = 0.01).
The genetic predisposition score, BMI and the obesity risk
The 31 SNPs were used to calculate a genetic pre-
disposition score (GPS), which was normally distributed
(mean: 27.7 ± 3.7 alleles; range: 13.8 to 38.9). We observedsignificant associations between the GPS and several an-
thropometric variables (such as BMI, body fat percentage,
waist circumference and hip circumference; Table 1). The
mean [95% confidence interval (CI)] allele effect of the GPS
was +0.13 [0.07-0.20] kg/m2 (p = 6.3x10−5) for BMI,
+0.14 [0.05-0.24]% (p = 0.004) for body fat percentage,
+0.28 [0.11-0.45] cm (p = 0.001) for waist circumference
and +0.24 [0.11-0.37] cm (p = 3.7x10−4) for hip circum-
ference. We did not detect a statistically significant asso-
ciation between the GPS and WHR.
Similar results were obtained after taking into account
missing genotypes (Additional file 1: Table S4). Associa-
tions between the GPS and the waist and hip circum-
ferences disappeared after further adjustment for BMI.
We also investigated the possible effect of interactions
between the GPS and gender, physical activity (PA),
smoking status and alcohol consumption on anthro-
pometric variables but did not detect any significant in-
teractions (data not shown).
To distinguish between the effects of the GPS and
the effects of the covariables classically associated with
BMI (age, gender, PA, smoking status and alcohol con-
sumption), we compared the crude and adjusted models
(Table 2). The GPS alone accounted for 1% of the variance
in the BMI, whereas the covariables accounted for 6%.
Overall, the GPS and the covariables explained 7% of the
variance in the BMI.
We also investigated the association between the GPS
and the obesity risk. Each additional BMI-raising allele
was associated with a 3% increase in the obesity risk
(OR [95% CI] = 1.03 [1.00-1.07]; p = 0.047).
The genetic predisposition score, glucose-related traits
and the type 2 diabetes risk
Given that obesity is an important determinant of gly-
caemic traits and insulin resistance, we assessed the asso-
ciation between the GPS on one hand and fasting plasma
glucose, HbA1c and insulin levels, the HOMA-IR and
HOMA-B scores and the risk of T2D on the other. We
Table 2 Effects of the crude and adjusted genetic
predisposition score on BMI in the MONA LISA Lille study
(n = 1546)
Models β SE LCL UCL p Explained variance (%)
Model 1 0.14 0.03 0.07 0.20 5.4x10−5 1.0
Model 2 0.13 0.03 0.07 0.2 6.3x10−5 7.0
The β coefficients represent the effect sizes. SE: standard error. LCL: lower
confidence limit; UCL: upper confidence limit.
Model 1: crude p value. Model 2: p value adjusted for age, gender, physical
activity, smoking status and alcohol consumption.
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and higher fasting plasma glucose (β ± SE = +0.017 ±
0.008 mmol/L, p = 0.04), insulin (β ± SE = +0.14 ± 0.06
μIU/mL, p = 0.008) and HbA1c levels (β ± SE = +0.012 ±
0.005%, p = 0.01) and a higher HOMA-IR (β± SE = +0.06 ±
0.02, p= 0.0003) (Table 3). The GPS was also significantly
associated with a higher risk of T2D (adjusted OR [95%
CI] = 1.06 [1.00-1.11], p = 0.03). However, these asso-
ciations were no longer statistically significant after adjust-
ment for BMI.
Discussion
Although the MONA LISA Lille study’s statistical power
was too low (68%) to detect significant individual associa-
tions, 25 of the 31 investigated SNPs presented effects
with the expected direction. Moreover, the effect alleles
for the FTO rs9939609 and FANCL rs887912 SNPs were
nominally associated with higher BMI. The GPS (corre-
sponding to the cumulative contribution of the 31 vali-
dated BMI-associated SNPs) showed a significant, positive
association with BMI. Each additional effect allele was as-
sociated with a mean increment of 0.13 kg/m2 in the BMI
(which corresponds to a weight increment of 376 g for a
person measuring 1.70 m in height) and a 3% increase in
the risk of obesity. The GPS was also significantly associ-
ated with body fat percentage and waist and hip circum-
ferences, although the last two associations did not resist
adjustment for BMI (suggesting that they were driven by
overall general adiposity). The genetic susceptibility asso-
ciated with the GPS explained only 1% of the variance in
the BMI, whereas the combined effect of known lifestyleTable 3 Associations between the genetic predisposition score
β SE
Fasting glucose (mmol/L) 0.017 0.008
Fasting insulin (μIU/mL) 0.14 0.06
HbA1c (%) 0.012 0.005
HOMA-IR 0.06 0.02
HOMA-B 1.17 0.63
The β coefficients represent the effect sizes. SE: standard error. LCL: lower confiden
Model 1: values were adjusted for age, gender, physical activity, smoking status and
Model 2: values were adjusted for age, gender, physical activity, smoking status, alcfactors accounted for 6%. Although it is clear that (i) gen-
etic factors account for 40–70% of the population vari-
ation in BMI and (ii) the 31 SNPs studied here have been
robustly validated as BMI-susceptible variants in GWASs
and replication studies, the SNPs’ combined effect on BMI
and the obesity risk was quite small. However, our results
are in agreement with previous reports [8,10,11].
Gene-environment interactions may also account for
variance in the BMI. Several studies have reported that PA
is associated with a reduction in the GPS’s impact on BMI
[12,13]. Like others [12], we failed to detect significant in-
teractions between the GPS and PA when considering sev-
eral anthropometric traits (BMI, body fat percentage, waist
and hip circumferences and WHR). Our failure to detect
this interaction is probably due to the relatively small sam-
ple size. In fact, very large sample sizes are needed when
exploring this type of interaction. For example, Ahmad
et al. showed that a population size of 20,000 is required to
detect a βGE interaction effect of −0.07 kg/m
2 [13].
Given that obesity is a major risk factor for insulin re-
sistance [14], the accumulation of obesity risk alleles may
alter glucose metabolism and predispose the individual to
T2D. To evaluate this hypothesis, we looked at whether
the GPS was associated with glucose-related variables and
the T2D risk in the MONA LISA Lille study. Indeed, we
found significant associations between the GPS on one
hand and higher fasting plasma glucose, insulin and
HbA1c levels and insulin resistance on the other. We also
showed that each additional BMI-raising allele was associ-
ated with a 6% increment in the T2D risk. Our results in a
general population sample are consistent with previous re-
ports. In a French case–control study, each additional allele
in the GPS was associated with higher insulin resistance
and a 3% increase in the T2D risk [15]. In the EPIC pro-
spective cohort study, each additional allele in the GPS was
also associated with a 4% increase in the T2D risk [10]. In
both these previous studies (as in the present study), all the
statistically significant associations were abolished after ad-
justment for BMI - meaning that overall general adiposity
explained the association between the GPS and insulin
resistance or T2D.and glucose-related variables in the MONA LISA Lille study
LCL UCL Model 1 Model 2
p p
0.001 0.033 0.04 0.35
0.03 0.24 0.008 0.46
0.003 0.021 0.01 0.10
0.03 0.10 0.0003 0.10
−0.07 2.42 0.18 0.83
ce limit; UCL: upper confidence limit.
alcohol consumption.
ohol consumption and BMI.
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Our results showed that the combination of common gen-
etic variants was moderately associated with BMI and
BMI-related variables in a sample of the general population
from northern France. Despite the fact that the heritability
of BMI is estimated to be 40-70% [5], the combination of
31 validated, BMI-associated loci only explained only 1% of
the variance in the BMI (i.e. less than 2-4% of the heritabi-
lity) [8]. Hence, characterization of this unexplained heri-
tability requires other approaches.
Methods
The MONA LISA Lille study
The MONA LISA (Monitoring National du Risque
Artériel; National Monitoring of Arterial Risk) Lille
study was a population-based, cross-sectional study of a
representative sample of 1578 participants recruited
from within the Lille urban area in northern France. In
accordance with the French legislation on biomedical
research, the study protocol was approved by the appro-
priate independent ethics committee (Comité Consulta-
tif de Protection des Personnes dans la Recherche
Biomédicale de Lille) and written informed consent was
obtained from all participants. The study design and
methods are described in the Additional file 1: methods.
Briefly, anthropometric traits were recorded during a
physical examination of each individual and a blood
sample was collected (for DNA extraction and clinical
biochemistry assays). The BMI was calculated according
to the Quetelet equation. Obesity was defined as a BMI
of 30 kg/m2 or more. Type 2 diabetes was defined ac-
cording to the 1997 American Diabetes Association def-
inition (fasting plasma glucose ≥ 7.0 mmol/l and/or
treatment for diabetes, including diet and/or oral antidi-
abetic drugs and/or insulin) [16].
Genotyping
Single nucleotide polymorphisms were genotyped using
KASPar technology (KBioscience, Hoddesdon, UK). The
genotyping success rates ranged from 98.1% to 99.6%.
Statistical analysis
Statistical analyses were performed with SAS 9.1 soft-
ware (SAS Institute Inc., Cary, NC, USA).
The Hardy-Weinberg equilibrium was tested using a χ2
test with one degree of freedom.
The GPS was derived as described previously [17].
Briefly, a weighting method was used to calculate the
GPS on the basis of 31 SNPs. Each SNP was weighted
according to its relative effect size (i.e. the β coefficient).
In order to measure the effect of each SNP on BMI with
greater accuracy and precision, β coefficients were de-
rived as described by Speliotes et al. [8]. We rescaled the
weighted scores to reflect the number of risk alleles.Hence, each point on the GPS corresponded to one risk
allele. When calculating the GPS, missing genotype data
were replaced with the average allele count for the cor-
responding SNPs. However, individuals with missing ge-
notypes for more than 10% of the loci were excluded
from the GPS analyses (n = 30).
We used general linear regression models to test the
associations of individual BMI-related SNPs and the
GPS with adiposity-related traits (including BMI, body
fat percentage, WHR, waist circumference and hip cir-
cumference) and glucose-related traits (assuming an
additive effect of the BMI-increasing alleles). A logistic
regression model was used to test the association be-
tween the GPS and the risk of obesity or T2D. Interac-
tions between the GPS on one hand and gender, PA,
smoking status and alcohol consumption on the other
were tested by including the GPS, interaction variables
and the interaction terms (GPS x interaction variables)
in general linear regression models.
The associations between genetic variants and BMI,
obesity and interactions were adjusted for age, gender,
smoking status, PA and alcohol consumption. The asso-
ciations between genetic variants and body fat percen-
tage, WHR, waist circumference and hip circumference
were adjusted for age, gender, smoking status, PA, and al-
cohol consumption including or not BMI, depending of
models. The associations between genetic variants and
biological parameters and the T2D risk were adjusted for
age, gender, BMI, smoking status, PA and alcohol con-
sumption. Data distributions for plasma glucose and insu-
lin levels and HOMA-IR and HOMA-B scores were
normalized by log transformation.
Bonferroni correction was used to adjust for the
Hardy-Weinberg equilibrium and for the multiple test-
ing in the individual obesity-related trait analyses. The
threshold for statistical significance was set to p ≤ 0.0016
(for 31 independent SNPs). Nominal significance was
defined as 0.0016 < p < 0.05.
For the GPS analyses, the threshold for statistical sig-
nificance was set to p ≤ 0.05.
The power calculations for association analyses (per-
formed a priori using Quanto v1.2.4 software (http://
biostats.usc.edu/Quanto.html) on the basis of the
mean BMI values from the MONA LISA Lille study
and the effect allele frequencies and effect sizes origin-
ally reported by Speliotes et al. [8]) indicated that the
statistical power of our study (for detecting a signifi-
cant association between an individual SNP and BMI
with a one-sided p value of 0.05) was 68%.
The power calculations for the GPS analysis were per-
formed using the pwr package developed by Stéphane
Champely. The statistical power for detecting significant
association between GPS and BMI (using a p value at
0.05) was 99%.
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The MONA LISA Lille study.
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